Literature DB >> 345441

Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.

A M Lefer, M L Ogletree, J B Smith, M J Silver, K C Nicolaou, W E Barnette, G P Gasic.   

Abstract

Prostacyclin, a potent, naturally occurring prostaglandin exerts a variety of cardiovascular and cellular actions of potential value in acute myocardial ischemia. These properties include the reduction of systemic blood pressure without changing heart rate, the lowering of coronary vascular and total peripheral resistance, the inhibition of platelet aggregation and the concomitant formation of thromboxane B2, and the reduction of the release of lysosomal enzymes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 345441     DOI: 10.1126/science.345441

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  43 in total

1.  Beneficial effect of beraprost, a prostacyclin-mimetic agent, on post-hypoxic recovery of cardiac function and metabolism in rabbit isolated hearts.

Authors:  K Tanonaka; Y Maruyama; S Takeo
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig.

Authors:  W J van der Giessen; B Schoutsen; J G Tijssen; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

3.  Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin.

Authors:  M Monden; J G Fortner
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

4.  Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

Authors:  C J Hawkey; N K Boughton-Smith; B J Whittle
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

5.  Effects of iloprost, a PGI2 derivative, on ischemic myocardial energy and carbohydrate metabolism in dogs.

Authors:  K Ichihara; K Yamamoto; Y Abiko
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

6.  The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.

Authors:  S Hassan; H Pickles; A Fish; C Burke; S Warrington; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

7.  Effect of prostacyclin infusion during low-flow ischaemia in the isolated perfused rat heart.

Authors:  W G Nayler; M Purchase; G J Dusting
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

8.  Effects of beraprost on the transmembrane potentials of guinea-pig ventricular muscles during normoxia and hypoxia-reoxygenation.

Authors:  Y Ueno; K Shigenobu; S Nishio
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

9.  An adrenergic participation subserving a positive inotropism and chonotropism of prostacyclin on isolated rat atria.

Authors:  L S Borda; L Cangas; M F Gimeno; A L Gimeno
Journal:  Experientia       Date:  1979-04-15

10.  Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.

Authors:  V B Fiedler; M Mardin
Journal:  Basic Res Cardiol       Date:  1986 Jan-Feb       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.